Patent ID: 9308205
Filing Date: 2016-04-12
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A pharmaceutical composition comprising a therapeutically effective amount of a 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride solvate excluding 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride monohydrate crystalline modification H2: Form H2: and a therapeutically effective amount of at least one additional pharmaceutically active substance selected from C225 and Erlotinib.